UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+0.05%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$3.52B
AUM Growth
+$53.7M
(+1.5%)
Cap. Flow
-$42.8M
Cap. Flow
% of AUM
-1.22%
Top 10 Holdings %
Top 10 Hldgs %
49.92%
Holding
595
New
104
Increased
143
Reduced
92
Closed
93
Top Buys
| 1 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$150M |
| 2 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$129M |
| 3 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$127M |
| 4 |
MRO
Marathon Oil Corporation
MRO
|
+$127M |
| 5 |
CHX
ChampionX
CHX
|
+$95.7M |
Top Sells
Sector Composition
| 1 | Energy | 26.72% |
| 2 | Technology | 21.14% |
| 3 | Healthcare | 14.79% |
| 4 | Industrials | 8.25% |
| 5 | Materials | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Keros Therapeutics
KROS
$628M
| $1.03M | 0.03% |
22,453
+5,400
| +32% | +$247K |
|
277
Astria Therapeutics
ATXS
$419M
| $1.03M | 0.03% |
112,665
+4,545
| +4% | +$41.4K |
|
278
Orthofix Medical
OFIX
$581M
| $1.02M | 0.03% |
76,998
-7,251
| -9% | -$96.1K |
|
279
PTC Therapeutics
PTCT
$4.52B
| $1.01M | 0.03% |
33,000
+18,000
| +120% | +$550K |
|
280
Axogen
AXGN
$738M
| $996K | 0.03% |
137,575
| – | – |
|
281
Arcus Biosciences
RCUS
$1.22B
| $993K | 0.03% |
65,187
+1,065
| +2% | +$16.2K |
|
282
Penumbra
PEN
$11.1B
| $989K | 0.03% |
5,498
-300
| -5% | -$54K |
|
|
SMAR
283
DELISTED
Smartsheet Inc.
SMAR
| $988K | 0.03% |
+22,416
| New | +$988K |
|
284
Deckers Outdoor
DECK
$17.4B
| $968K | 0.03% |
+6,000
| New | +$968K |
|
285
Arcos Dorados Holdings
ARCO
$1.44B
| $963K | 0.03% |
+107,023
| New | +$963K |
|
286
Karyopharm Therapeutics
KPTI
$54.2M
| $957K | 0.03% |
73,493
+25,338
| +53% | +$330K |
|
287
Vertiv
VRT
$46.5B
| $952K | 0.03% |
11,000
-54,300
| -83% | -$4.7M |
|
288
Insmed
INSM
$31B
| $949K | 0.03% |
14,169
-39,338
| -74% | -$2.64M |
|
289
Abbott
ABT
$230B
| $935K | 0.03% |
+9,000
| New | +$935K |
|
290
BridgeBio Pharma
BBIO
$10.4B
| $925K | 0.03% |
+36,500
| New | +$925K |
|
|
INZY
291
DELISTED
Inozyme Pharma
INZY
| $915K | 0.03% |
205,218
+22,000
| +12% | +$98.1K |
|
292
B2Gold
BTG
$5.68B
| $904K | 0.03% |
+334,874
| New | +$904K |
|
|
TRIS
293
DELISTED
Tristar Acquisition I Corp.
TRIS
| $899K | 0.03% |
80,656
| – | – |
|
294
Camden Property Trust
CPT
$11.9B
| $898K | 0.03% |
8,227
+3,852
| +88% | +$420K |
|
295
Peloton Interactive
PTON
$3.3B
| $879K | 0.02% |
+260,000
| New | +$879K |
|
296
Shopify
SHOP
$190B
| $859K | 0.02% |
13,000
+6,500
| +100% | +$429K |
|
297
LiveRamp
RAMP
$1.81B
| $851K | 0.02% |
27,500
-157,500
| -85% | -$4.87M |
|
298
Perspective Therapeutics
CATX
$255M
| $848K | 0.02% |
+85,013
| New | +$848K |
|
299
Teleflex
TFX
$5.75B
| $841K | 0.02% |
+4,000
| New | +$841K |
|
|
RVNC
300
DELISTED
Revance Therapeutics, Inc.
RVNC
| $836K | 0.02% |
325,314
+70,647
| +28% | +$182K |
|